Results
SD
SEPARATION
The results of primary outcomes of the trial have been reported [Baseline characteristics of study participants by treatment group.Data presented as mean ± SD or median (IQR).Baseline plasma concentrations of EPA, DPA, DHA, AA and their derived lipid mediators in non-responders versus responders in the combined active treatment arms (EPA 1 g/d, 2 g/d, and 4 g/d).Median (IQR); *The changes in plasma EPA, DHA and AA, defined as the difference between week 12 and baseline, were similar in responders and non-responders within each treatment arm (Supplementary figure). A non-significant trend (The PLS-DA score plot of the changes in lipid mediators derived from EPA, DHA, and AA in all subjects receiving active EPA supplementation indicated a partial separation of responders and non-responders (Fig. 